BARALDI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 4.915
EU - Europa 3.395
AS - Asia 1.998
SA - Sud America 386
Continente sconosciuto - Info sul continente non disponibili 97
AF - Africa 65
OC - Oceania 6
Totale 10.862
Nazione #
US - Stati Uniti d'America 4.803
FI - Finlandia 1.981
SG - Singapore 633
CN - Cina 552
BR - Brasile 308
DE - Germania 292
IT - Italia 282
VN - Vietnam 269
PL - Polonia 205
HK - Hong Kong 154
GB - Regno Unito 130
TR - Turchia 129
SE - Svezia 117
UA - Ucraina 105
FR - Francia 82
RU - Federazione Russa 72
CA - Canada 63
IN - India 50
BD - Bangladesh 43
JP - Giappone 37
ID - Indonesia 33
ZA - Sudafrica 31
MX - Messico 29
BE - Belgio 26
AR - Argentina 23
NL - Olanda 23
IQ - Iraq 19
ES - Italia 18
AT - Austria 15
CL - Cile 13
EG - Egitto 12
CO - Colombia 11
EC - Ecuador 11
UZ - Uzbekistan 11
IL - Israele 7
PK - Pakistan 7
TN - Tunisia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
TW - Taiwan 6
UY - Uruguay 6
AU - Australia 5
LT - Lituania 5
PY - Paraguay 5
SA - Arabia Saudita 5
CR - Costa Rica 4
IE - Irlanda 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
MD - Moldavia 4
NP - Nepal 4
BG - Bulgaria 3
BY - Bielorussia 3
MA - Marocco 3
MY - Malesia 3
NI - Nicaragua 3
PH - Filippine 3
RO - Romania 3
TH - Thailandia 3
AL - Albania 2
AZ - Azerbaigian 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
JM - Giamaica 2
KH - Cambogia 2
MN - Mongolia 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GL - Groenlandia 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MC - Monaco 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NA - Namibia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
Totale 10.763
Città #
Helsinki 1.931
Dallas 775
Ashburn 517
Singapore 433
Fairfield 360
Woodbridge 354
San Jose 272
Ann Arbor 207
Warsaw 201
Beijing 192
Chandler 178
Houston 173
Santa Clara 158
Hong Kong 147
Seattle 144
Wilmington 138
Jacksonville 123
Cambridge 120
Ferrara 108
Council Bluffs 101
Los Angeles 87
Ho Chi Minh City 77
Munich 74
New York 66
Izmir 58
Hanoi 56
Milan 47
Shanghai 43
Nanjing 38
Tokyo 37
Princeton 34
Dong Ket 31
Boardman 29
London 29
São Paulo 29
Brussels 26
Lauterbourg 26
Turku 25
San Diego 23
Orem 21
Buffalo 20
Toronto 20
Bremen 19
Frankfurt am Main 19
Jakarta 19
Addison 18
Brooklyn 16
Chicago 16
Montreal 16
Amsterdam 15
Phoenix 15
Asnières-sur-Seine 14
Nanchang 14
Shenyang 14
Stockholm 13
Mexico City 12
Baghdad 11
Denver 11
Haiphong 11
Jiaxing 11
Atlanta 10
Changsha 10
Chennai 10
Des Moines 10
Hebei 10
Johannesburg 10
Poplar 10
Tashkent 10
Brasília 9
Cairo 9
Curitiba 9
Da Nang 9
Moscow 9
Querétaro 9
Rio de Janeiro 9
San Francisco 9
Ankara 8
Falls Church 8
Irvine 8
Tianjin 8
Washington 8
Belo Horizonte 7
Hefei 7
Mcallen 7
Redwood City 7
Biên Hòa 6
Boston 6
Cape Town 6
Cergy 6
Guangzhou 6
Hải Dương 6
Jinan 6
Manchester 6
Montevideo 6
Montréal 6
Mumbai 6
Norwalk 6
Philadelphia 6
Santiago 6
Vancouver 6
Totale 8.102
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.122
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 345
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 331
Design and Synthesis of New A2B Adenosine Receptor Antagonists 319
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 317
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 304
2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition 304
A3 adenosine receptor antagonists: History and future perspectives 297
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 286
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 274
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 273
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 260
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 254
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 249
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 246
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 236
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 231
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 220
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 213
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 206
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 204
3-Aryl/Heteroaryl-5-amino-1-(3′,4′,5′-trimethoxybenzoyl)-1,2,4-triazoles as antimicrotubule agents. Design, synthesis, antiproliferative activity and inhibition of tubulin polymerization 188
A 2a adenosine receptor: Structures, modeling, and medicinal chemistry 178
Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cells 177
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 171
Adenosine Receptors in Colon Carcinoma Tissues and Colon Tumoral Cell Lines: Focus on the A3 Adenosine Subtype 166
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists 148
Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists 143
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists. 141
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors 133
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists 130
null 121
null 118
null 103
Synthesis and Biological Evaluation of Novel 2-Amino-3-Aroyl-4-Neopentyl-5-Substituted Thiophene Derivatives as Allosteric Enhancers of the A1 Adenosine Receptor 101
null 96
null 90
null 84
null 83
Totale 10.862
Categoria #
all - tutte 35.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.109
Totale 38.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022390 0 0 34 25 36 34 23 24 27 40 36 111
2022/2023438 41 59 8 67 58 55 37 33 47 2 21 10
2023/2024273 19 21 13 9 32 61 8 34 2 6 4 64
2024/20251.063 30 50 92 47 102 96 73 63 144 74 149 143
2025/20265.536 313 308 784 361 442 238 373 159 2.118 282 125 33
2026/2027336 92 187 57 0 0 0 0 0 0 0 0 0
Totale 10.862